SECsense Logo

Entero Therapeutics, Inc. 8-K Report Highlights for February 2025

$ENTO
Form 8-K
Filed on: 2025-02-14
Source
Entero Therapeutics, Inc. 8-K Report Highlights for February 2025

Based on the provided section of the financial report, here are the key insights and important information extracted:

  1. Entity Information:
  • Company Name: Entero Therapeutics, Inc.
  • CIK Number: 0001604191
  • SEC File Number: 001-37853
  • EIN: 46-4993860
  • Address: 777 Yamato Road, Suite 502, Boca Raton, FL 33431
  • Phone Number: 561-589-7020
  1. Filing Details:
  • Filing Type: 8-K (Current Report)
  • Filing Date: February 12, 2025
  1. Securities Information:
  • Common Stock: The company has common stock with a par value of $0.0001 per share.
  • Ticker Symbol: ENTO
  • Exchange: NASDAQ
  1. Reporting Period:
  • Report Date: The report is for the end date of February 12, 2025.
  • Context ID: AsOf2025-02-12
  1. Financial Metrics:
  • The report includes financial metrics expressed in USD and Shares, but specific numerical values or additional financial data are not included in the provided text.
  1. XML and XBRL Details:
  • The report is structured using XBRL (eXtensible Business Reporting Language), which is a standardized format for financial reporting.

This information provides a snapshot of Entero Therapeutics, Inc.'s current financial reporting status as of February 12, 2025, including key identifiers, filing details, and securities-related information. Further analysis would require additional data, such as financial statements or operational metrics, which are typically included in a complete 8-K filing.